Cargando…
Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma
Autores principales: | Yasuda, Hajime, Tsukune, Yutaka, Watanabe, Naoki, Sugimoto, Kazuya, Uchimura, Ayana, Tateyama, Misa, Miyashita, Yosuke, Ochi, Yusuke, Komatsu, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442568/ https://www.ncbi.nlm.nih.gov/pubmed/32933879 http://dx.doi.org/10.1016/j.clml.2020.08.017 |
Ejemplares similares
-
Resolution of One-Year Persisting COVID-19 Pneumonia and Development of Immune Thrombocytopenia in a Follicular Lymphoma Patient With Preceding Rituximab Maintenance Therapy: A follow-up Report and Literature Review of Cases With Prolonged Infections
por: Yasuda, Hajime, et al.
Publicado: (2021) -
Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin
por: Uchimura, Ayana, et al.
Publicado: (2022) -
Maintenance rituximab in Veterans with follicular lymphoma
por: Halwani, Ahmad S., et al.
Publicado: (2020) -
Rituximab maintenance therapy of follicular lymphoma in clinical practice
por: Dührsen, Ulrich, et al.
Publicado: (2018) -
Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma
por: Tsukune, Yutaka, et al.
Publicado: (2019)